浏览全部资源
扫码关注微信
1.甘肃中医药大学,兰州 730000
2.甘肃省中医方药挖掘与创新转化重点实验室,兰州 730000
3.甘肃省中药新产品创制工程实验室,兰州 730000
胡韵韵,在读硕士,从事中医复方物质基础及作用机制研究,E-mail:269713183@qq.com
王虎平,博士,副教授,博士生导师,从事中医复方物质基础及作用机制研究,E-mail:whp@gszy.edu.cn
纸质出版日期:2024-09-05,
网络出版日期:2024-06-17,
收稿日期:2024-04-22,
扫 描 看 全 文
胡韵韵,吕育洁,孟志鹏等.基于cAMP/PKA/NMDAR信号通路探讨黑逍遥散对APP/PS1双转基因AD小鼠海马神经元突触可塑性的影响[J].中国实验方剂学杂志,2024,30(17):27-34.
HU Yunyun,LYU Yujie,MENG Zhipeng,et al.Hei Xiaoyaosan Affects Synaptic Plasticity of Hippocampal Neurons in APP/PS1 Double Transgenic Mice of AD via cAMP/PKA/NMDAR Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(17):27-34.
胡韵韵,吕育洁,孟志鹏等.基于cAMP/PKA/NMDAR信号通路探讨黑逍遥散对APP/PS1双转基因AD小鼠海马神经元突触可塑性的影响[J].中国实验方剂学杂志,2024,30(17):27-34. DOI: 10.13422/j.cnki.syfjx.20240744.
HU Yunyun,LYU Yujie,MENG Zhipeng,et al.Hei Xiaoyaosan Affects Synaptic Plasticity of Hippocampal Neurons in APP/PS1 Double Transgenic Mice of AD via cAMP/PKA/NMDAR Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(17):27-34. DOI: 10.13422/j.cnki.syfjx.20240744.
目的
2
探究黑逍遥散通过调控环磷酸腺苷(cAMP)/蛋白激酶A(PKA)/
N
-甲基-
D
-天冬氨酸受体(NMDAR)信号通路干预APP/PS1小鼠突触可塑性的作用及其机制。
方法
2
选取4月龄雄性C57BL/6J小鼠12只作空白组,同月龄雄性APP/PS1双转基因小鼠60只,随机分为模型组、KW-6002(腺苷受体的拮抗剂)组(3 mg·kg
-1
)及黑逍遥散高、中、低剂量组(22.10、11.05、5.53 g·kg
-1
),每组12只,对应药物连续干预90 d。透射电镜观察海马神经元突触超微结构,高尔基染色观察海马CA1区神经元树突棘密度,蛋白免疫印迹法(Western blot)检测cAMP、PKA、
N
-甲基-
D
-天冬氨酸受体1(NR1)、
N
-甲基-
D
-天冬氨酸受体2A(NR2A)、
N
-甲基-
D
-天冬氨酸受体2B(NR2B)、突触后致密物质95(PSD95)、突触蛋白1(SYN1)的蛋白表达,实时荧光定量聚合酶链式反应(Real-time PCR)检测cAMP、PKA、NR1的mRNA表达,酶联免疫吸附测定法(ELISA)检测小鼠海马白细胞介素-12(IL-12)、白细胞介素-4(IL-4)含量。
结果
2
与空白组比较,模型组小鼠海马CA1区突触前膜与突触后膜分界线清晰程度欠佳,突触囊泡明显减少且分布散乱,突触后膜密度降低,海马CA1区神经元树突棘形态欠规整,排列不连续、密度减少(
P
<
0.01),海马cAMP、PKA、NR1、NR2A、NR2B、PSD95、SYN1的蛋白表达降低(
P
<
0.01),cAMP、PKA、NR1的mRNA表达下调(
P
<
0.01),海马IL-12含量增多、IL-4含量减少(
P
<
0.01);与模型组比较,各用药组小鼠海马CA1区突触前膜与后膜分界线清晰明了且结构完整,突触囊泡增多,排列密集,突触后膜密度增加,神经元树突棘形态较为规则,排列连续,成熟型树突棘密度增多(
P
<
0.05,
P
<
0.01),海马cAMP、PKA、NR1、NR2A、NR2B、PSD95、SYN1的蛋白表达增加(
P
<
0.05,
P
<
0.01),cAMP、PKA、NR1的mRNA表达提高(
P
<
0.01),海马IL-12含量降低(
P
<
0.01),IL-4含量增加(
P
<
0.01)。
结论
2
黑逍遥散能改善APP/PS1小鼠海马神经元结构形态,其作用机制可能与激活cAMP/PKA/NMDAR信号通路、修复突触可塑性有关。
Objective
2
To explore the effect and mechanism of Hei Xiaoyaosan in modulating the synaptic plasticity in APP/PS1 mice by regulating the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA)/
N
-methyl-
D
-aspartate receptor (NMDAR) signaling pathway.
Method
2
Twelve 4-month-old male C57BL/6J mice were selected as the blank control group, and 60 4-month-old male APP/PS1 double transgenic mice were randomized into model, KW-6002 (adenosine receptor antagonist, 3 mg·kg
-1
), and high-, medium-, and low-dose (22.10, 11.05, 5.53 g·kg
-1
, respectively) Hei Xiaoyaosan groups, with 12 mice in each group. Mice were administrated with corresponding drugs for 90 days. Transmission electron microscopy was employed to observe the synaptic ultrastructure of hippocampal neurons, and Golgi staining was used to observe the dendritic spine density of neurons in hippocampal CA1 region. Western blot was employed to measure the protein levels of cAMP, PKA,
N
-methyl-
D
-aspartate receptors 1, 2A, and 2B (NR1, NR2A, and NR2B, respectively), postsynaptic density protein 95 (PSD95), and synapsin 1 (SYN1). Real-time fluorescence quantitative polymerase chain reaction(Real-time PCR) was performed to determine the mRNA levels of cAMP, PKA, and NR1. Enzyme-linked immunosorbent assay was employed to determine the content of interleukin-12 (IL-12) and interleukin-4 (IL-4) in the hippocampus.
Result
2
Compared with the blank group, the model group showed blurred boundaries between presynaptic membrane and postsynaptic membrane in hippocampal CA1 region, reduced and scattered synaptic vesicles, and decreased density of postsynaptic membrane, and irregular, disarranged, and loosened dendritic spines of neurons in hippocampal CA1 region (
P
<
0.01). In addition, the model group presented down-regulated protein levels of cAMP, PKA, NR1, NR2A, NR2B, PSD95, and SYN1 and mRNA levels of cAMP, PKA, and NR1, elevated IL-12 level, and lowered IL-4 level in the hippocampus (
P
<
0.01). Compared with the model group, the drug intervention groups showed clear and intact boundaries between presynaptic membrane and post
synaptic membrane in hippocampal CA1 region, increased synaptic vesicles with dense arrangement, increased density of postsynaptic membrane, and improved morphology, arrangement, and density of neuronal dendritic spines (
P
<
0.05,
P
<
0.01). In addition, the drug interventions up-regulated the protein levels of cAMP, PKA, NR1, NR2A, NR2B, PSD95, and SYN1 (
P
<
0.05,
P
<
0.01) and mRNA levels of cAMP, PKA, and NR1 (
P
<
0.01), lowered the IL-12 level (
P
<
0.01), and elevated the IL-4 level (
P
<
0.01) in the hippocampus.
Conclusion
2
Hei Xiaoyaosan can improve the structure and morphology of hippocampal neurons in APP/PS1 mice by activating the cAMP/PKA/NMDAR signaling pathway and repairing synaptic plasticity.
黑逍遥散阿尔茨海默病突触可塑性环磷酸腺苷(cAMP)/蛋白激酶A(PKA)/N-甲基-D-天冬氨酸受体(NMDAR)信号通路
Hei XiaoyaosanAlzheimer's diseasesynaptic plasticitycyclic adenosine monophosphate (cAMP)/protein kinase A (PKA)/N-methyl-D-aspartate receptor (NMDAR) signaling pathway
JUCKER M,WALKER L C.Alzheimer's disease: From immunotherapy to immunoprevention[J].Cell,2023,186(20):4260-4270.
SCHELTENS P,DE STROOPER B,KIVIPELTO M,et al.Alzheimer's disease[J].Lancet,2021,397(10284):1577-1590.
ESSAYAN-PEREZ S,SÜDHOF T C.Neuronal γ-secretase regulates lipid metabolism, linking cholesterol to synaptic dysfunction in Alzheimer's disease[J].Neuron,2023,111(20):3176-3194.e7.
KOCH G,SPAMPINATO D.Alzheimer disease and neuroplasticity[J].Handb Clin Neurol,2022,184:473-479.
PENG L,BESTARD-LORIGADOS I,SONG W.The synapse as a treatment avenue for Alzheimer's disease[J].Mol Psychiatry,2022,27(7):2940-2949.
SKEBERDIS V A,CHEVALEYRE V,LAU C G,et al.Protein kinase A regulates calcium permeability of NMDA receptors[J].Nat Neurosci,2006,9(4):501-510.
于婧文,郭敏芳,李梦迪,等.黄芪甲苷通过影响NogoA/NgR和cAMP/PKA通路改善APP/PS1转基因小鼠认知功能[J].中国病理生理杂志,2023,39(7):1188-1198.
LEONARD A S,HELL J W.Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites[J].J Biol Chem,1997,272(18):12107-12115.
李明成,周君,胡韵韵,等.黑逍遥散调控NOX2/ROS/NF-κB信号通路干预AD模型小鼠小胶质细胞极化[J].中国中药杂志,2023,48(15):4027-4038.
王虎平,米彩云,李明成,等.基于“三阴并调”探讨黑逍遥散对AD模型大鼠海马神经元及PP2A的影响及作用机制[J].中药药理与临床,2022,38(4):40-45.
王虎平,米彩云,周君,等.黑逍遥散通过调控PP2A/GSK-3β通路对阿尔茨海默病大鼠的改善作用[J]. 中成药, 2022, 44(10): 3311-3314.
王虎平,胡韵韵,吕育洁,等.黑逍遥散调控p38 MAPK/Beclin-1/Bcl-2通路对阿尔茨海默病模型大鼠自噬水平的影响[J].中国中药杂志,2024,doi:10.19540/j.cnki.cjcmm.20240216.101http://dx.doi.org/10.19540/j.cnki.cjcmm.20240216.101.
王虎平,吕育洁,胡韵韵,等.基于RAS/RAF/MEK/ERK信号通路探讨黑逍遥散干预AD模型大鼠氧化应激的作用机制[J].中国实验方剂学杂志,2024,30(17):35-42.
吕育洁,胡韵韵,孟志鹏,等.黑逍遥散干预阿尔茨海默病的述评与展望[J].中国实验方剂学杂志,2024,30(17):43-50.
王虎平,陈怡琴,杨娇,等.黑逍遥散调控Fas/FasL/Caspase-8/Caspase-3信号通路对AD大鼠神经元细胞凋亡的影响[J].中国实验方剂学杂志,2024,30(17):18-26.
王桂娥,庞春燕,陆丽珠.逍遥散的临床新用 [J]. 中国中医药信息杂志,2003, S1: 64-65.
徐叔云,卞如濂,陈修.《药理实验方法学》[M].2版. 北京:人民卫生出版社,1992: 19.
OLIVEROS A,YOO K H,RASHID M A,et al.Adenosine A(2A) receptor blockade prevents cisplatin-induced impairments in neurogenesis and cognitive function[J].Proc Natl Acad Sci USA,2022,119(28):e2206415119.
TWAROWSKI B,HERBET M.Inflammatory processes in Alzheimer's disease-pathomechanism, diagnosis and treatment:A review[J].Int J Mol Sci,2023,24(7):6518.
ZHENG K,HU F,ZHOU Y,et al.miR-135a-5p mediates memory and synaptic impairments via the Rock2/Adducin1 signaling pathway in a mouse model of Alzheimer's disease[J].Nat Commun, 2021, 12(1): 1903.
MA S,ZUO Y.Synaptic modifications in learning and memory-A dendritic spine story[J].Semin Cell Dev Biol,2022,125:84-90.
MCQUATE A,BARRIA A.Rapid exchange of synaptic and extrasynaptic NMDA receptors in hippocampal CA1 neurons[J].J Neurophysiol,2020,123(3):1004-1014.
KÖHR G.NMDA receptor function:Subunit composition versus spatial distribution[J].Cell Tissue Res,2006,326(2):439-446.
YU S P,JIANG M Q,SHIM S S,et al.Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: Implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease[J].Mol Neurodegener,2023,18(1):43.
郭自贺,王祎,朱梦姚,等.十全大补汤通过调节突触功能对阿尔兹海默病小鼠认知损伤的改善作用[J].中成药,2024,46(1):72-78.
MA W,LU K,LIANG H M,et al.Synapsin 1 ameliorates cognitive impairment and neuroinflammation in rats with alzheimer's disease:An experimental and bioinformatics study[J].Curr Alzheimer Res,2023,20(9):648-659.
COLEY A A,GAO W J.PSD95:A synaptic protein implicated in schizophrenia or autism?[J].Prog Neuropsychopharmacol Biol Psychiatry,2018,82:187-194.
WANG J,HE X,GUO F,et al.Multiple kinases involved in the nicotinic modulation of gamma oscillations in the rat hippocampal CA3 area[J].Front Cell Neurosci,2017,11:57.
WESTPHAL R S,TAVALIN S J,LIN J W,et al.Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex[J].Science,1999,285(5424):93-96.
ARNSTEN A,DATTA D,WANG M.The genie in the bottle-magnified calcium signaling in dorsolateral prefrontal cortex[J].Mol Psychiatry,2021,26(8):3684-3700.
王潇潇,李群,杨超,等.基于cAMP/PKA/PGC1α信号通路探讨恒古骨伤愈合剂改善肌筋膜疼痛综合征大鼠能量代谢的作用机制[J].中国实验方剂学杂志,2023,29(24):54-62.
CHEN W H,JIN W,LYU P Y,et al.Carotid atherosclerosis and cognitive impairment in nonstroke patients[J].Chin Med J (Engl),2017,130(19):2375-2379.
孟丹华,佘楷杰,孟晓莹,等.基于NLRP3/Caspase-1/IL-1β通路探讨温阳解郁方调节小鼠海马突触可塑性的机制[J].中国实验方剂学杂志,2024,30(6):39-47.
0
浏览量
10
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构